Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Sees Significant Increase in Short Interest

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the recipient of a large growth in short interest in the month of June. As of June 30th, there was short interest totaling 29,843 shares, a growth of 285.9% from the June 15th total of 7,733 shares. Based on an average trading volume of 9,737 shares, the short-interest ratio is currently 3.1 days. Currently, 3.3% of the company’s stock are sold short.

Virtus LifeSci Biotech Products ETF Trading Down 3.2%

Shares of BBP traded down $3.36 on Friday, reaching $100.26. The stock had a trading volume of 12,899 shares, compared to its average volume of 8,038. The company has a 50-day simple moving average of $89.98 and a 200-day simple moving average of $85.28. Virtus LifeSci Biotech Products ETF has a 12-month low of $60.80 and a 12-month high of $105.21.

Hedge Funds Weigh In On Virtus LifeSci Biotech Products ETF

A number of institutional investors have recently added to or reduced their stakes in the company. Flow Traders U.S. LLC purchased a new position in Virtus LifeSci Biotech Products ETF during the second quarter valued at $431,000. Prime Capital Investment Advisors LLC purchased a new stake in shares of Virtus LifeSci Biotech Products ETF in the fourth quarter worth $1,896,000. Finally, Comprehensive Financial Planning Inc. PA bought a new position in shares of Virtus LifeSci Biotech Products ETF during the fourth quarter valued at $557,000.

Virtus LifeSci Biotech Products ETF Company Profile

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.